Skip to main content
Clinical Trials/TCTR20211111007
TCTR20211111007
Not yet recruiting
Phase 3

Effects of exercise program on lung function, physical fitness and innate immunity against Mycobacterium tuberculosis in close contacts

the project TB/MDR-TB research capacity building in low- and middle-income countries in the Southeast Asia under the fund of Fogarty International Center/ National Institute of Health (NIH)0 sites60 target enrollmentNovember 11, 2021

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
close contact with TB/MDR-TB patients
Sponsor
the project TB/MDR-TB research capacity building in low- and middle-income countries in the Southeast Asia under the fund of Fogarty International Center/ National Institute of Health (NIH)
Enrollment
60
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 11, 2021
End Date
May 31, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
the project TB/MDR-TB research capacity building in low- and middle-income countries in the Southeast Asia under the fund of Fogarty International Center/ National Institute of Health (NIH)

Eligibility Criteria

Inclusion Criteria

  • 1\. People who living with TB/MDR\-TB patients for 2 months, will select only one person in the household that meets the inclusion criteria.
  • 2\. Tuberculin skin test negative (TST less or equal to 15 mm)
  • 3\. Age 20 to 40 year
  • 4\. Body weight more than 50 kg
  • 5\. Cooperation and can participate at least 2 months of the program
  • 6\. No immune deficiency condition and not take an immunosuppressive drug
  • 7\. Nonexercise participant, for example, does not work that requires physical exertion or exercise regularly
  • 8\. The maximum oxygen consumption (VO2max) less than 40 ml/kg/min
  • 9\. Not have precaution of exercise

Exclusion Criteria

  • 1\. Chronic pulmonary disease
  • 2\. Infectious arthritis
  • 3\. Underlying of diabetes mellitus
  • 4\. History of HIV\+
  • 5\. Use supplement products /food
  • 6\. Pregnancy
  • 7\. Anemia (Hb less than 7 g/dL)

Outcomes

Primary Outcomes

Not specified

Similar Trials